Data on cancer risk from hormone therapy 'reassuring,' menopause experts say (IMAGE)
Caption
The lack of higher mortality with combined estrogen and progesterone therapy is reassuring for women with a uterus who have been concerned about using hormone therapy at menopause,” said Carolyn S. Wilson, MD, a menopause expert at UVA Health.
Credit
UVA Health
Usage Restrictions
May be used to accompany news coverage of the hormone therapy editorial. All other uses require express written permission from UVA Health.
License
Original content